| Autor: |
Davies, P. S., Rhodes, J., Counsell, Barbara, Evans, B. K. |
| Předmět: |
|
| Zdroj: |
American Journal of Gastroenterology (Springer Nature); Aug1980, Vol. 74 Issue 2, p150-152, 3p, 1 Diagram, 2 Charts, 1 Graph |
| Abstrakt: |
PRD-92 a well-absorbed mast cell stabilizer was examined in patients with ulcerative colitis by a double-blind controlled trial. Forty-three patients who were in clinical remission and taking sulfasalazine were randomly allocated to treatment with sulfasalazine or PRD-92 for six months. Relapses occurred in 42% of patients on PRD-92 and 24% on sulfasalazine. PRD-92 has a less prophylactic effect than sulfasalazine in ulcerative colitis. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
